International Journal of Antimicrobial Agents
Volume 35, Issue 5 , Pages 482-485 , May 2010

Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone

Received 11 April 2009 ,Accepted 22 December 2009.

References 

  1. Crump JA. The global burden of typhoid fever. Bull World Health Organ. 2004;82:346–353
  2. Ackers ML, Puhr ND, Tauxe RV, Mintz ED. Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise. JAMA. 2000;283:2668–2673
  3. Turner AK, Nair S, Wain J. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets. J Antimicrob Chemother. 2006;58:733–740
  4. Saha SK, Talukder SY, Islam M, Saha S. A highly ceftriaxone-resistant Salmonella Typhi in Bangladesh. Pediatr Infect Dis J. 1999;18:387
  5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. Document M100-S15. Wayne, PA: CLSI; 2005.
  6. Sambrook J, Russell DW. Molecular cloning: a laboratory manual. 3rd ed.. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2001;p. 1.31–1.38
  7. Kariuki S, Revathi G, Kariuki N, Kiiru J, Mwituria J, Hart CA. Characterization of multidrug-resistant typhoid outbreaks in Kenya. J Clin Microbiol. 2004;42:1477–1482
  8. Das U, Bhattacharya SS. Antibiogram, phage typing and biotyping of Salmonella Typhi and Salmonella Paratyphi A from Rourkela, Orissa. Indian J Med Res. 2006;124:109–111
  9. Chitnis S, Chitnis V, Hemvani N, Chitnis DS. Ciprofloxacin therapy for typhoid fever needs reconsideration. J Infect Chemother. 2006;12:402–404
  10. Walia M, Gaind R, Mehta R, Paul P, Aggarwal P, Kalaivani M. Current perspectives of enteric fever: a hospital-based study from India. Ann Trop Paediatr. 2005;25:161–174
  11. Raveendran R, Wattal C, Sharma A, Oberoi JK, Prasad KJ, Datta S. High level ciprofloxacin resistance in Salmonella enterica isolated from blood. Indian J Med Microbiol. 2008;26:50–53
  12. Thong KL, Bhutta ZA, Pang T. Multidrug-resistant strains of Salmonella enteric serotype Typhi are genetically homogenous and coexist with antibiotic-sensitive strains as distinct, independent clones. Int J Infect Dis. 2000;4:194–197
  13. Chau TT, Campbell JI, Galindo CM, Van Minh Hoang N, Diep TS, Nga TT, et al. Antimicrobial drug resistance of Salmonella enterica serovar Typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother. 2007;51:4315–4323
  14. Renuka K, Kapil A, Kabra SK, Wig N, Das BK, Prasad VV, et al. Reduced susceptibility to ciprofloxacin and gyrA gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A. Microb Drug Resist. 2004;10:146–153
  15. Cooke FJ, Wain J, Threlfall EJ. Fluoroquinolone resistance in Salmonella Typhi. BMJ. 2006;333:353–354
  16. Threlfall EJ, Skinner JA, Ward LR. Detection of decreased in vitro susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A. J Antimicrob Chemother. 2001;48:740–741
  17. Riesenfeld C, Everett M, Piddock LJ, Hall BG. Adaptive mutations produce resistance to ciprofloxacin. Antimicrob Agents Chemother. 1997;41:2059–2060

PII: S0924-8579(10)00023-3

doi: 10.1016/j.ijantimicag.2009.12.020

International Journal of Antimicrobial Agents
Volume 35, Issue 5 , Pages 482-485 , May 2010

Article Tools

* Image Usage & Resolution